COMMON STOCK PURCHASE WARRANT AGILE THERAPEUTICS, INC.Agile Therapeutics Inc • March 1st, 2021 • Pharmaceutical preparations • New York
This Warrant is issued pursuant to that certain Credit Agreement and Guaranty dated as of February 10, 2020 (the “Credit Agreement”) by and among the Company, as borrower, the subsidiaries of the Company from time to time party thereto as guarantors, the lenders from time to time party thereto, and Holder, as administrative agent for the lenders, as amended by the First Amendment to Credit Agreement and Guaranty dated as of the date hereof.
FIRST AMENDMENT TO PROJECT AGREEMENT (DETAILING – FIELD TEAM AND TELESOLUTIONS)First Amendment • March 1st, 2021 • Agile Therapeutics Inc • Pharmaceutical preparations
This First Amendment (the “Amendment”) dated June 1, 2020 (the “Effective Date”) is made by and between inVentiv Commercial Services, LLC, a Syneos Health® group company, with an office at 500 Atrium Drive, Somerset, N.J. 08873 (“Syneos Health”) and Agile Therapeutics, Inc. with an office located at 100 Poor Farm Road, Princeton, New Jersey 08540 (the “Client”). Syneos Health and Client may each be referred to herein as a “Party” and, collectively, as the “Parties.”
WAIVER AND FIRST AMENDMENT TO CREDIT AGREEMENT AND GUARANTYCredit Agreement • March 1st, 2021 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
This Waiver and First Amendment to Credit Agreement and Guaranty (herein, this “Agreement”) is entered into as of February 26, 2021 (the “First Amendment Effective Date”), by and among Agile Therapeutics, Inc., a Delaware corporation (the “Borrower”), the Lenders party hereto (each a “Lender” and collectively, the “Lenders”) and Perceptive Credit Holdings III, LP, a Delaware limited partnership, as a lender and as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).
